# Influenza Vaccination of HIV Infected Pregnant Women: Safety and Immunogenicity

> **NCT01306682** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Witwatersrand, South Africa** · enrollment: 194 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Trivalent influenza vaccine
- **BIOLOGICAL:** Normal saline

## Key facts

- **NCT ID:** NCT01306682
- **Lead sponsor:** University of Witwatersrand, South Africa
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-06
- **Final completion:** 2012-07
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2013-02-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306682, "Influenza Vaccination of HIV Infected Pregnant Women: Safety and Immunogenicity". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01306682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*